Frequency Domain Near-Infrared
Spectroscopy. Clinical Applications for the Study of the Oxygenation and Hemodynamics of
the Brain and Muscle
Antonios Michalos, M.D., M.S.
Director of Medical Research ISS, Inc.
Senor Research Scientist
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN Beckman Institute for Advanced Science and Technology
Department of Mechanical Science and Engineering Department of Physics
E-mail: antonios.michalos@iss.com
OUTLINE
Frequency Domain Multidistance NIRS
• Instrumentation
OxiplexTS
Multidistance Sensors
FAQs and Answers
Applications
• Neurovascular surgery
• ICU post operative monitoring
• Obstructive Sleep Apnea Syndrome
• Age correlated changes
• Attention Deficit Hyperactivity Disorder
• Activation of Brain Areas
• Muscle Hemodynamic Changes in PVD
NIRS nel Dominio delle Frequenze.
Applicazioni Cliniche della Spetroscopia e Ossimetria del Cervello e del Muscolo
Emitter Detector
Reflected Collected
Absorbed
Light in
Why Near-Infrared Spectroscopy?
Non-invasive
Non-ionizing
Comfortable
Portable
Cost effective
Fast
Reliable
Real-time monitoring
of tissue oxygenation and hemodynamics
Why Frequency Domain Near-Infrared Spectroscopy of Biological Tissues
FD-NIRS separates absorption from scattering to obtain absolute values of hemoglobin concentration and tissue oxygen saturation
Main NIRS parameters:
Oxygenated hemoglobin, [O
2Hb]
Deoxygenated hemoglobin, [HHb]
Total hemoglobin, [tHb] = [O
2Hb]+ [HHb]
Tissue oxygenation, SO
2=[O
2Hb]/[tHb]
Frequency-Domain Tissue Oximeter
(Developed at LFD-UIUC, Built by ISS Inc., Champaign, IL, USA).
Modulation Frequency: 110 MHz
Light sources: 8 laser diodes at 690 nm 8 laser diodes at 830 nm
(electronically multiplexed at 40Hz) Detectors: 2 photomultiplier tubes
Multi distance Method
Dual Sensor Probe
(for bilateral frontal lobe measurements)
Light source fibers Detector fiber
Detector fibers:1 per channel (3 mm internal diameter)
Source fibers:4 pairs of fibers (emitting 690 nm and 830 nm respectively) per channel
Source-detector distance: Range 2-4 cm (multi-distance approach)
Cerebral hemodynamic
changes during voluntary hypoxia
Altered Hemodynamic responses to breath holding in subject with severe cardiovascular disease.
Decrease in [HHb]
Increase in [O2Hb]
Hemodynamic responses to breath holding in a healthy individual
Increase in [O2Hb]
Decrease in [HHb]
Healthy subject
Cardiovascular patient
Questions from the medical community:
Does the FD-NIRS and the multidistance approach probe the brain?
Which are the appropriate source-detector distances?
What proof can we give that the findings are not influenced by the superficial tissues.
Experimental approaches:
Brain vascular responsiveness to voluntary hypoxia with and without partial scalp ischemia.
Clamping of external and internal carotid arteries
during neurovascular surgery
Light source fibers Detector fiber
Partial scalp ischemia induced by a head tourniquet
a)
Breath Holding Exercises on 11 healthy volunteers
Without tourniquet With tourniquet
Whole array SDD 1.08 cm-4.38 cm
10 15 20 25 30 35 40 45
100 120 140 160 180
time, s
[tHb], [O2Hb],[HHb], m M/l
-2 -1 0 1 2 3 4
RS, A.U.
Respiratory Signal [tHb]
[O 2 Hb]
[HHb] 10 15
20 25 30 35 40 45
780 800 820 840 860
time, s
[tHb], [O2Hb],[HHb], m M/l
-2 -1 0 1 2 3 4
RS, A.U.
[tHb]
[O 2 Hb]
Respiratory Signal [HHb]
c) b)
SDD
1.08 cm-1.98 cm
(Superficial Tissues)
SDD
1.98 cm-4.38 cm
(Deep Tissues)
10 14 18 22 26 30 34 38
100 120 140 160 180
time, s [tHb], [O2Hb],[HHb],m M/l
-5 -4 -3 -2 -1 0 1
RS, A.U.
Respiratory Signal
[tHb]
[O Hb] 2 [HHb]
10 15 20 25 30 35 40 45
100 120 140 160 180
time, s [tHb], [O2Hb],[HHb],m M/l
-2 -1 0 1 2 3 4
RS, A.U.
[tHb]
2
[HHb]
Respiratory Signal
[O Hb]
Clamping of External vs. Internal Carotid Artery
in a Patient with Defective Left to Right Brain Vascular Anastomotic Communication during Neurovascular Surgery
NORMAL BRAIN ARTERIAL
CIRCULATION
External Carotid Artery Clamping
No change brain oxygenation and hemodynamics
Internal Carotid Artery Clamping
Significant changes in brain oxygenation and Hemodynamics
Conclusions
Brain vascular response to hypoxia with and without partial scalp ischemia.
Clamping of external and internal carotids during neurovascular surgery
Q. Does the FD-NIRS and multidistance approach probe the brain?
A. By measuring light simultaneously at multiple distances we reduce the contribution of the superficial layer. Optical properties of the superficial layer have no influence on time-of-flight.
Q. Which are the appropriate source-detector distances?
A. Light collected at 2-4 cm travels deeper into tissue and reaches the surface of the brain.
Q. Is our method working?
A. By looking at the details of brain hemodynamics during ischemia we differentiated spatial and temporal hemodynamic changes in the brain.
NIRS in Neurosurgery and ICU Post-Operative monitoring
University of Illinois at Chicago Medical Center Chicago, Illinois
Overall Trace
Monitoring of Brain Oxygenation
and Hemodynamics after Surgery
Near-Infrared Brain Oximetry in Obstructive Sleep Apnea Syndrome
University of Illinois at Urbana Champaign Laboratory for Fluorescence Dynamics
ISS Inc., Champaign, Illinois
Carle Foundation Hospital-Sleep Center Urbana , Illinois
University of Illinois at Chicago Medical Center
Center of Sleep and Ventilatory Disorders
Sleep apnea.
The cessation of airflow through the nose and mouth during sleep that lasts for more than 10 seconds.Sleep apnea syndrome (SAS). At least 30 apneic episodes observed during a 7-hour sleep period.
SAS types: 1. Obstructive (OSAS) 2. Central
3. Mixed
24% of males and 9% of females have 5 or more apneas per hour
12% of men and 5% of women present more severe forms (more than 15 apneas per hour)
OSAS in middle age adults has been identified in approximately 4% of men and 2% in women
In elderly estimates range from 28% to 67% in men and 20% to 54% in women
Sleep apnea: Risks
Social and professional impairment
Traffic and work accidents
Cardiovascular/pulmonary complications a. Systemic hypertension
b. Pulmonary hypertension c. Cardiac arrhythmias
d. Ischemic heart disease
e. Alteration of the vascular wall
Cerebrovascular complications
a. Neuropsychological dysfunction b. Cognitive deficits
c. Transient ischemic attacks d. Strokes
Death
POLYSOMNOGRAPHY
(sleep study)Monitoring of:
Snoring
Respiratory effort Naso-oral airflow Recordings of:
Electrocardiogram (EKG)
Electroencephalogram (EEG)
Bilateral electro-oculogram (EOG)
Bilateral anterior tibialis Electromyogram (EMG) Submental electromyogram (EMG)
Arterial oximetry
But………it does not provide the clinician with information on cerebral oxygenation and hemodynamics, which are important parameters one wishes to determine.
Measurement protocol
Breath holding exercises
• 3-4 min baseline
• breath holding at FRC with resumption of breathing (3-5 times)
• 5-10 min baseline recovery
• Repetition of breath holding and
resumption of breathing (3-5 times)
NIRS measurements during sleep
Changes in cerebral hemodynamics with respect to baseline values
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20time, s 40
D[O2Hb], D[HHb], mmol/L
Respiratory signal, AU
D[HHb]
D[O2Hb]
OSA subject
Decrease in [O2Hb]
Increase in [HHb]
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 time, s
D[O2Hb], D[HHb], mmol/L Respiratory signal, AU D[O2Hb]
D[HHb]
Changes in [O2Hb] and [HHb]
due to intermittent sleep apnea OSA subject
BREATH HOLDING
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 time, s
D[O2Hb], D[HHb], mmol/L Respiratory signal, AU D[O2Hb]
D[HHb]
Control non-snorer
Increase in [O2Hb]
Decrease in [HHb]
DIURNAL NAPPING
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 time, s 40
D[O2Hb], D[HHb], mmol/L Respiratory signal, AU
D[HHb]
D[O2Hb]
Opposite-phase changes in [O2Hb] and [HHb] due to vasomotion and
regular breathing Control non-snorer
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 time, s
D[O2Hb], D[HHb], mmol/L
Snorer
Respiratory signal, AU
D[HHb]
D[O2Hb]
Opposite-phase changes in [O2Hb] and [HHb] due to vasomotion and irregular
breathing
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 time, s 40
D[O2Hb], D[HHb], mmol/L
Snorer
Respiratory signal, AU
D[O2Hb]
D[HHb]
Delayed increase in [O2Hb]
Slight decrease in [HHb]
Capillaries are the "heart" of the circulatory system, all the action is in the capillaries, and all other blood vessels
merely assist them.
The blood flow across the capillary bed is regulated by a sphincter muscle on the arteriole side. Whenever there is little need to
supply blood to a given capillary bed, the sphincter closes and blood bypasses the capillary bed via an arterio-venal shunt.
The cerebrovascular response to hypoxia (decreased O2) and hypercapnia (increased CO2) is vasodilation and opening of the capillary bed.
9 subjects (3716 years) 52 breath holdings
(25 11 s) 12 subjects (3810 years)
72 breath holdings (30 19 s)
8 subjects (4916 years) 58 breath holdings
(18 7 s)
Changes in total hemoglobin concentration during breath holding
Voluntary Breath Holding Duration, s -1
0 1 2 3 4 5 6 7 8 9
0 20 40 60 80 100 120
Breath Hold Duration, s
Change in tHb concentration, μmol/L
1
2
1 - area of tHb changes observed for control subjects 2 - area of tHb changes observed for OSAS subjects
0.60.9 22.315.8
OSAS
(8 subjects/ 8sessions/ 26 breath holds)
2.92.3 42.024.1
Controls
(8 subjects/ 8sessions/ 31 breath holds)
d[tHb]
dt
Change in tHb concentration,
μmol/L Duration of the
breath holding, s
Subjects
(matched in number, age and sex)
Changes in brain tissue total hemoglobin concentration (changes in cerebral blood volume)
1 - area of changes in control non-snorers 2 - area of changes in OSA sufferers
-2 0 2 4 6 8
Breath holding duration, s
Change in [t Hb], μ mol/L
0 20 40 60 80
1
2
65 70 75 80 85 90 95 100
1200 1250 1300 1350 1400
time, s
SaO2, %; SO2, %
-2 -1 0 1 2 3
Breathing, AU
10 15 20 25 30 35 40
1200 1250 1300 1350 1400
time, s
[tHb]; [O2Hb]; [HHb], mcM/L
-2 -1 0 1 2 3
Breathing, AU
10 15 20 25 30 35 40 45
1600 1650 1700 1750 1800
time, s
[tHb]; [O2Hb]; [HHb], mcM/L
-4 -2 0 2 4 6 8
Breathing, AU
60 65 70 75 80 85 90 95 100
1600 1650 1700 1750 1800
time, s
SaO2, %; SO2, %
-6 -4 -2 0 2 4 6
Breathing, AU
tHb tHb
Breathing
Breathing
Breathing
Breathing O2Hb
HHb HHb
SO2
SaO2
SO2
SaO2
O2Hb
Control subject OSA subject
a)
b)
c)
d)
Changes in brain hemodynamics and tissue oxygenation during sleep
(a,b) control subject, (c,d) OSA subject
Arterial blood oxygen saturation (SaO2 ) is measured via pulse oximetry.
Breathing is monitored via a strain gauge around the chest.
Brain tissue oxygenation (SO2) and tissue hemoglobin oxygen saturation are measured by NIRS
Right Frontal Lobe: Oxy-Hb (Red) Deoxy-Hb (Blue) Left Frontal Lobe: Oxy-Hb (Light Blue)
Deoxy-Hb (Green) Breathing (Black)
Pulse (Gray)
Breath holding
Time (sec)
Sleep Apnea
Time (sec)
sufferer OSA
Control Hemodynamic responses to hypoxia
Characterization of the subjects based on changes in [O2Hb] and [HHb] due to breathing during sleep
1 - severe OSA subjects;
2 - youngest OSA subjects (29 & 44 years old) 3 - snorer with a family history of OSA ; 4 - oldest snorer (73 years old);
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s
D[O2Hb], D[HHb], mmol/L
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s
D[O2Hb], D[HHb], mmol/L
Respiratory signal, AU
D[O2Hb]
D[HHb]
Respiratory signal, AU D[HHb]
D[O2Hb]
Control non-snorer
OSA subject Breath holding
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s
D[O2Hb], D[HHb], mmol/L
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s
D[O2Hb], D[HHb], mmol/L
Respiratory signal, AU
Respiratory signal, AU D[HHb]
D[O2Hb]
D[O2Hb]
D[HHb]
Control non-snorer
OSA subject Durnal nap
Diurnal napping Breath hold ing
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s
D[O2Hb], D[HHb], mmol/L
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s
D[O2Hb], D[HHb], mmol/L
Respiratory signal, AU
D[O2Hb]
D[HHb]
Respiratory signal, AU D[HHb]
D[O2Hb]
Control non-snorer
OSA subject Breath holding
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s
D[O2Hb], D[HHb], mmol/L
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s
D[O2Hb], D[HHb], mmol/L
Respiratory signal, AU
Respiratory signal, AU D[HHb]
D[O2Hb]
D[O2Hb]
D[HHb]
Control non-snorer
OSA subject Durnal nap
Diurnal napping Breath hold ing
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s D[O2Hb], D[HHb],mmol/L
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s D[O2Hb], D[HHb],mmol/L
Respiratory signal, AU
D[O2Hb]
D[HHb]
Respiratory signal, AU D[HHb]
D[O2Hb]
Control non-snorer
OSA subject Breath holding
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s
D[O2Hb], D[HHb],mmol/L -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s D[O2Hb], D[HHb],mmol/L
Respiratory signal, AU
Respiratory signal, AU D[HHb]
D[O2Hb]
D[O2Hb]
D[HHb]
Control non-snorer
OSA subject Durnal nap
Diurnal napping Breath holding
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s D[O2Hb], D[HHb],mmol/L
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 10 20 30 40
Time period during breath holding, s D[O2Hb], D[HHb],mmol/L
Respiratory signal, AU
D[O2Hb]
D[HHb]
Respiratory signal, AU D[HHb]
D[O2Hb]
Control non-snorer
OSA subject Breath holding
-2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s
D[O2Hb], D[HHb],mmol/L -2.0 -1.0 0.0 1.0 2.0 3.0 4.0 5.0
0 20 40 60
Time period during daytime napping, s D[O2Hb], D[HHb],mmol/L
Respiratory signal, AU
Respiratory signal, AU D[HHb]
D[O2Hb]
D[O2Hb]
D[HHb]
Control non-snorer
OSA subject Durnal nap
Diurnal napping Breath holding
Probability of opposite phase changes in [O2Hb]
and [HHb] due to respiration sleep, %
0 20 40 60 80 100
0 20 40 60 80 100
Right hemisphere
Left hemisphere
Non-snorers Snorers OSA subjects 1
3
4
2
We track the intra-hemispheric temporal correlations to observe anti-correlation or anti-phase behavior with respect to the changes in oxy- and deoxy-Hb, which is
displayed as an angle of 180 degrees.
Phase LeftPhase RightPhase Ox% R+L
Phase LeftPhase RightPhase Ox% R+L Phase LeftPhase RightPhase Ox% R+L
Phase LeftPhase RightPhase Ox% R+L
Healthy Control: six hours of sleep in histogram [column 1]
OSAS: three hours of sleep with multiple apneic events [column 2, red box]
CPAP: three hours of sleep in OSAS subject with CPAP [column 3, red box]
(Split PSG study: OSAS subject is diagnosed and fitted with CPAP for apneic event reduction therapy.)
Analysis Schemes:
The Hilbert Transform provides two types of temporal information: (1) we can track the correlations in time and (2) we can analyze all the points in time as a histogram.
The figures show the histograms of the inter-hemispheric oxygenation (Ox%)
Conclusion
NIRS provides non-invasive, transcranial, real-time measurements of cerebral oxygenation and hemo- dynamics.
NIRS gives direct information on cerebrovascular autoregulation.
NIRS may provide a cost-effective screening for cerebrovascular morbidity in OSAS sufferers.
NIRS may be associated with the standard
overnight polysomnography to monitor brain
vascular responsiveness to hypoxia in OSAS.
Age correlated changes in cerebral hemodynamics assessed by near-infrared
spectroscopy
Changes in oxy- and deoxy-hemoglobin concentrations assessed in a control non-snorer during breath holding
-1.5 0.0 1.5 3.0
0 8 16 24
Breath holding duration, s D[O2Hb] and D[HHb], mmol/L
D[O2Hb]
D[HHb]
Analyzed changes in cerebral hemodynamic parameters
on the 12
thsecond of breath holding and mean changes
during the 8
th– 16
thseconds (shaded area).
-3.0 -2.0 -1.0 0.0 1.0 2.0 3.0 4.0
20 30 40 50 60
Age, years D[O2Hb],mmol/L
Pearson Correlation r=-0.43*; p=0.025
N=27
-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0
20 30 40 50 60
Age, years D[HHb],mmol/L
Pearson Correlation r=0.49**; p=0.009
N=27
-3.0 0.0 3.0 6.0 9.0
20 30 40 50 60
Age, years
DSO2, %
Pearson Correlation r=-0.48*; p=0.011
N=27 -3.0
-2.0 -1.0 0.0 1.0 2.0 3.0
20 30 40 50 60
Age, years D[tHb],mmol/L
Pearson Correlation r=-0.27; p=0.167
N=27
Decreases in
D[O
2Hb],
D[tHb], and
DSO
2, and an increase in
D
[HHb] during hypoxic episodes were observed in older subjects.
NIRS in Attention Deficit Hyperactivity Disorder (ADD/ADHD)
Collaborative Project
University of Illinois at Urbana-Champaign Laboratory for Fluorescence Dynamics
Carle Clinic, Urbana Illinois
UIUC College of Medicine, Department of Pediatrics
The University of Texas
Southwestern Medical Center at Dallas
Department of Pediatrics
ADHD - Attention Deficit Hyperactivity Disorder
The most common psychiatric developmental disorder in USA
Qualitative Diagnosis
• Hyperactive type: “always on the go”
• Inattentive type: “struggle to stay focus”
• Mixed type: the most common
• Symptoms must be constant and across settings
Hypoperfusion hypothesis
• abnormal distribution of regional Cerebral Blood Flow (rCBF)
• frontal lobes, frontal-striatal-cerebellar circuits
• volumetric evaluation: PET, MRI, CT
Methylphenidate
• stimulates the release/block of reuptake of extracellular dopamine in the synaptic cleft.
• reduces inattentive, impulsive, and hyperactive symptoms.
0 5 10 15 C_ABS_DIF
0 5 10 15 20
A_NO_ABS_DIF
Absolute Oxygenation Difference (%)
Control
ADHD without medication
0 5 10 15 20
A_NO_ABS_DIF
0 5 10 15 20
A_M_ABS_DIF ADHD without medication
ADHD with medication
Absolute Oxygenation Difference (%)
Potential Diagnostic Screening
7 years old control child
Tapping exercise, Right hand.
-0.015 -0.01 -0.005 0 0.005 0.01 0.015
0 50 100 150 200 250 300 350
0 1
-0.015 -0.01 -0.005 0 0.005 0.01 0.015
0 50 100 150 200 250 300 350
0 1
D [H bO2] , D [H Hb] , m m ol/ L
Right Forehead
Left Forehead
Time (360 s), Tapping Periods (20 s)
7 years old ADHD hyperactive child Tapping exercise, Right hand. Showing
regional hypoperfusion?
-0.015 -0.01 -0.005 0 0.005 0.01 0.015
0 50 100 150 200 250 300 350
0 1
D detrended HbO2 A D detrended HHb A mark 5 per. Mov. Avg. ( D detrended HbO2 A) 5 per. Mov. Avg. (D detrended HHb A)
-0.015 -0.01 -0.005 0 0.005 0.01 0.015
0 50 100 150 200 250 300 350
0 1
D detrended HbO2 B D detrended HHb A mark 5 per. Mov. Avg. (D detrended HHb A) 5 per. Mov. Avg. (D detrended HbO2 B)
Right Forehead
Left Forehead
D [H bO2] , D [H Hb] , m m ol/ L
Time (360 s), Tapping Periods (20 s)
Final Remarks
• NIRS provides non-invasive, transcranial, real-time
measurements of cerebral oxygenation and hemodynamics.
• NIRS can measure absolute values of the concentrations of [HbO2], [HHb], and [tHb] and tissue oxygenation.
• NIRS aims to study specific hemodynamic patterns in ADHD:
• detect hypoperfusion with functional NIRS.
• detect brain development anomaly in populations of young children.
• assess brain segregation in the frontal lobes in ADHD.
• contribute to ADHD diagnosis and pharmacological treatment.
• More synchronous locations for measurements are needed.
Motor cortex activation
Collaborative project
University of Illinois at Urbana-Champaign Laboratory for Fluorescence Dynamics
Tufts University, Medford MA
Department of Electrical Engineering and computer Science
Plots of Source-Detector Pairs by DPF
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l -0.4
0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
-0.4 0 0.4 0.8 1.2
-10 0 10 20 30
time (s)
µmol/l
O2Hb
HHb stimulation
D [HHb] (mM)
-1.0 -0.5 0.0 0.5
6
7
8 1
2 3
4 B A
5
Motor cortex activation
Data acquisition frequency = 1.25Hz
6
7
8 1
2 3
4 B A
5
D [HHb] (mM)
-1.0 -0.5 0.0 0.5
Motor cortex activation
Data acquisition frequency = 1.25Hz
Simultaneous
measurement of fMRI and NIRS of brain function
Collaborative Project
University of Illinois at Urbana-Champaign Laboratory for Fluorescence Dynamics
Beckman Institute
Carle Hospital Foundation, Urbana IL
Simultaneous Multi-source Frequency-domain NIRS and BOLD fMRI signals during motor functional
activation in humans: Collocation of signals
0 5 10 15 20 25 30
0.1 0.2 0.3 0.4
0 5 10 15 20 25 30-0.2
-0.1 0
0 5 10 15 20 25 30
0 0.1 0.2
D[OHb] (mM) 2 0.3
0 5 10 15 20 25 30-0.2
0
0.2 D[HHb] (mM)
0 5 10 15 20 25 30
0 0.5 1 1.5
0 5 10 15 20 25 30-2
-1 0 1
0 5 10 15 20 25 30
-0.1 0 0.1 0.2
0 5 10 15 20 25 30-0.5
0 0.5
Time (s) Subject A
Subject B
Subject C
Subject D
0 5 10 15 20 25 30
0 2 4
6 R
BOLD P
0 5 10 15 20 25 30
0 0.2 0.4 0.6
0 5 10 15 20 25 30
1 2 3
0 5 10 15 20 25 30
0.2 0.4 0.6 0.8 1
0 5 10 15 20 25 30
0 1
)P(% 2
0 5 10 15 20 25 30
0 0.2 0.4
0 5 10 15 20 25 30
0 1 2
0 5 10 15 20 25 30
-0.2 0 0.2 0.4
R(%)
time (s)
Subject A
Subject B
Subject C
Subject D
R: [HHb]
P: [tHb]
The Absorption and Scattering of Intensity Modulated NIR Light is Measured in the
Tissue Beneath the Sensor
Light detector position
Light source position Sample
source detector
Peripheral Vascular Disease
ISS Inc.
University of Illinois at Urbana-Champaign Laboratory for Fluorescence Dynamics
UIUC College of Medicine, VA Hospital, Danville, Illinois The University of Texas
Southwestern Medical Center at Dallas, Department of VA
Policlinico Monteluce, University of Perugia, Italy
Peripheral Vascular Disease (PVD) is a
chronic condition characterized by poor
circulation in the extremities
PVD manifests as insufficient tissue perfusion
Blocked blood flow can cause pain and numbness.
It can result in dangerously low delivery of
Nutrients and Oxygen to tissues especially in the foot and lower leg
Affects 12-14% of General Population and >20%
of people over 75
Over 100,000 Surgical Interventions Per Year
Early Detection, Monitoring, and Treatment May
Improve Quality of Life and Reduce Surgeries
The Human Clinical Trial for PVD Assessment
Patient Groups
Healthy Controls 17 Subjects
At Risk- 29 Subjects
Intermittent Claudication 27 Subjects
Rest Pain 7 Subjects
Dialysis 15 Subjects
Protocol
Oximeter Monitoring Of Both Calves Simultaneously Stand
Walk On Treadmill, 2 MPH at 3% Incline Stand
Pre And Post Exercise ABI (Ankle Brachial Index) Also Measured
Tissue Oxygenation at Rest (Average and Standard
Deviation)
63.0 67.6
72.0 69.9
50 55 60 65 70 75 80
Healthy Controls
At Risk Intermittent Claudication
Rest Pain
Saturation %
50.6 48.3
68.7
60.8
30 40 50 60 70 80
Healthy Controls
At Risk Intermittent Claudication
Rest Pain
Saturation (%)
Tissue Oxygenation during Exercise
(Average and Standard Deviation)
Conclusion: There is a correlation between saturation attained during exercise and clinical condition.
the step function in the shaded areas indicates exercise load (on a stationary bicycle)
patients affected by peripheral vascular disease show:
larger desaturation during exercise
longer recovery time after exercise
healthy subject
PVD patient (stage II)
exercise exercise
time (min)
Tissue hemoglobin oxygen saturation (%)
Typical hemoglobin saturation traces
20 30 40 50 60 70 80 90
0 2 4 6 8 10 12 14 16
14
49
175
202
-50 0 50 100 150 200 250
Healthy Controls
At Risk Intermittent Claudication
Rest Pain
Seconds
Post Exercise Saturation Recovery Time
(Average and Standard Deviation)
Conclusion: There is a strong correlation between saturation recovery time after exercise and clinical condition
Right Calf
Previous Right Side Femoral Artery Bypass
30 40 50 60 70 80 90
0 300 600 900 1200 1500
0
Stand Walk Stand
50 60 70 80 90 100 110 120
0 300 600 900 1200 1500
0
Stand Walk Stand
20 30 40 50 60 70 80 90 100
0 300 600 900 1200 1500
0
Stand Walk Stand
20 30 40 50 60 70 80
0 300 600 900 1200 1500
0
Stand Walk Stand
Hemodynamic Analysis Case Study
Saturation (%) THC (µM)
[Oxy-Hb] (µM) [Deoxy-Hb] (µM)
Left Calf
Scheduled For Left Side Femoral Artery Bypass Angiogram Verified Left Femoral Occlusion
Summary and Conclusions
Baseline Saturation, Exercise Induced De-Saturation, and Post Exercise Saturation Recovery Time all
Correlate with Clinical Condition
Exercise Induced Saturation measurements may be effective for PVD assessment
Hemodynamic Analysis of Oximetry Data may provide
Diagnostic Information in addition to PVD Assessment
ISS Imagent™
We are able to create functional maps of the tissue
Maps of O2Hb during a venous occlusion of 3 minutes duration
cuff
subject with PVD, left leg
subject with mild PVD, right leg
normal subject, right leg
video runs 3 times faster than real time:
10s start of occlusion 70s end of occlusion
color scale in µM
Why Near-Infrared Spectroscopy and Imaging of Tissues?
Real-time monitoring of tissue oxygenation and hemodynamics
Non-invasive
Portable
Cost effective
Fast
Reliable
•University of Illinois at Urbana-Champaign
Laboratory for Fluorescence Dynamics Beckman Institute
•ISS Inc. Champaign, Illinois, U.S.A.
Grants R01 HD41342 R01 EB00559 R44 NS40597
•University of Illinois Medical Center at Chicago
Department of Neurosurgery
Center for Sleep and Ventilatory Disorders
•University of California, Irvine
Department Pediatrics
Developmental and Cell Biology Beckman Laser Institute
•The University of Texas Southwestern Medical Center at Dallas
Department of Pediatrics
Acknowledgements
•Carle Foundation Hospital, Urbana, Illinois
Department of Pediatrics Center for Sleep Disorders
•University of Kentucky
Sanders-Brown Center on Aging